Skip to content

Bioventus BVS Restructuring Charges

Restructuring Charges at other companies

Enovis logo
EnovisENOV
$2.71M-29.9%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$0-100%
Alphatec Holdings logo
Alphatec HoldingsATEC
$0-100%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's restructuring charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's restructuring charges?
Bioventus (BVS) reported restructuring charges of $454K in Q1 2026.
What is the long-term trend for Bioventus's restructuring charges?
Over 3 years (2021 to 2024), Bioventus's restructuring charges has grown at a -72.5% compound annual growth rate (CAGR), from $2.49M to -$52K.
What does restructuring charges mean?
One-time costs from reorganizing operations, including employee severance, facility closure costs, contract termination fees, and asset relocation expenses.